pHIV-EGFP.Flag-EZH2
(Plasmid
#220243)
-
PurposeExpresses wild-type EZH2 for knockout/rescue experiments in mammalian cells.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 220243 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepHIV-EGFP
-
Backbone manufactureraddgene Plasmid #21373
- Backbone size w/o insert (bp) 7746
- Total vector size (bp) 9995
-
Vector typeMammalian Expression, Lentiviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameEZH2
-
Alt nameEnhancer Of Zeste 2 Polycomb Repressive Complex 2
-
Alt nameHistone-lysine N-methyltransferase
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2934
-
GenBank IDQ15910
-
Entrez GeneEZH2 (a.k.a. ENX-1, ENX1, EZH2b, KMT6, KMT6A, WVS, WVS2)
- Promoter EF-1α
-
Tag
/ Fusion Protein
- Flag (N terminal on backbone)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer 5'-TGGAATTTGCCCTTTTTGAG-3'
- 3′ sequencing primer 5'-AGGAACTGCTTCCTTCACGA-3' (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pHIV-EGFP.Flag-EZH2 was a gift from Chen Davidovich (Addgene plasmid # 220243 ; http://n2t.net/addgene:220243 ; RRID:Addgene_220243) -
For your References section:
Inseparable RNA binding and chromatin modification activities of a nucleosome-interacting surface in EZH2. Gail EH, Healy E, Flanigan SF, Jones N, Ng XH, Uckelmann M, Levina V, Zhang Q, Davidovich C. Nat Genet. 2024 May 14. doi: 10.1038/s41588-024-01740-8. 10.1038/s41588-024-01740-8 PubMed 38744974